SCHEMBL28107477

SCHEMBL28107477

O=C(O)C1CCCN1Cc1cccc(C(F)(F)F)c1.[LiH]

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
SIGMAR1 Q99720 2/20 0.52
KDM4E B2RXH2 2/20 0.51
GAA P10253 1/20 0.51
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
S1PR1 P21453 1/20 0.49
GRK5 P34947 1/20 0.49
CDK8 P49336 1/20 0.49
S1PR5 Q9H228 1/20 0.49
CYP1A2 P05177 1/20 0.48
PTGER4 P35408 2/20 0.48
KDM2B Q8NHM5 1/20 0.48
FAAH O00519 1/20 0.47
LMNA P02545 1/20 0.47
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1009407 0.99 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2SIGMAR1KDM4EGAA
SCHEMBL17320112 0.99 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2SIGMAR1KDM4EGAA
SCHEMBL1817113 0.99 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2SIGMAR1KDM4EGAA
SCHEMBL28107109 0.88 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2SIGMAR1KDM4EGAA
SCHEMBL7314623 0.88 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2SIGMAR1KDM4EGAA
SCHEMBL27852999 0.85 ALDH1A1 (0.75) ALDH1A1SMN1; SMN2SIGMAR1KDM4EGAA
SCHEMBL2032041 0.83 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2SIGMAR1KDM4ECYP1A2
SCHEMBL21618307 0.83 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2SIGMAR1KDM4ECYP1A2
SCHEMBL1818801 0.83 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2SIGMAR1KDM4ECYP1A2
SCHEMBL2029008 0.82 MAOA (0.60) ALDH1A1SMN1; SMN2SIGMAR1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103702980-B Cyclic amine derivatives as EP 4 receptor antagonists 罗达制药生物技术有限责任公司 2016-10-05 CN disclosed